Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers ; volume:13 ; number:1 ; day:27 ; month:9 ; year:2024 ; pages:1-6 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (27.9.2024), 1-6, 12.2024
- Creator
-
Kotani, Hiroshi
Yamano, Tomoyoshi
Boucher, Justin C.
Sato, Shigeki
Sakaguchi, Hiroyuki
Fukuda, Koji
Nishiyama, Akihiro
Yamashita, Kaname
Ohtsubo, Koushiro
Takeuchi, Shinji
Nishiuchi, Takumi
Oshima, Hiroko
Oshima, Masanobu
Davila, Marco L.
Yano, Seiji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00563-x
- URN
-
urn:nbn:de:101:1-2412132109430.626705171924
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kotani, Hiroshi
- Yamano, Tomoyoshi
- Boucher, Justin C.
- Sato, Shigeki
- Sakaguchi, Hiroyuki
- Fukuda, Koji
- Nishiyama, Akihiro
- Yamashita, Kaname
- Ohtsubo, Koushiro
- Takeuchi, Shinji
- Nishiuchi, Takumi
- Oshima, Hiroko
- Oshima, Masanobu
- Davila, Marco L.
- Yano, Seiji
- SpringerLink (Online service)
Other Objects (12)
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Charakterisierung der Phosphatase PTPRO als MEK-Inhibitor-Primärresistenzmechanismus im KRAS-mutierten Kolonkarzinom
Impact of the Tumor Suppressor Arf on Miz1 and Sumoylation of Myc and Miz1
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
..mek
MEK
MEK
MEK
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Charakterisierung der Phosphatase PTPRO als MEK-Inhibitor-Primärresistenzmechanismus im KRAS-mutierten Kolonkarzinom
Impact of the Tumor Suppressor Arf on Miz1 and Sumoylation of Myc and Miz1
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
..mek
MEK
MEK
MEK
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Charakterisierung der Phosphatase PTPRO als MEK-Inhibitor-Primärresistenzmechanismus im KRAS-mutierten Kolonkarzinom
Impact of the Tumor Suppressor Arf on Miz1 and Sumoylation of Myc and Miz1
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
..mek
MEK
MEK
MEK
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway